Your browser doesn't support javascript.
loading
Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study.
Tanaka, Shogo; Noda, Takehiro; Komeda, Koji; Kosaka, Hisashi; Iida, Hiroya; Ueno, Masaki; Hokuto, Daisuke; Ikoma, Hisashi; Nakai, Takuya; Kabata, Daijiro; Shinkawa, Hiroji; Kobayashi, Shogo; Hirokawa, Fumitoshi; Mori, Haruki; Hayami, Shinya; Morimura, Ryo; Matsumoto, Masataka; Ishizawa, Takeaki; Kubo, Shoji; Kaibori, Masaki.
Afiliación
  • Tanaka S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan. shogotanaka@omu.ac.jp.
  • Noda T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Komeda K; Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Kosaka H; Department of Surgery, Hirakata Hospital, Kansai Medical University, Hirakata, Osaka, Japan.
  • Iida H; Division of Gastrointestinal, Breast, and General Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
  • Ueno M; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
  • Hokuto D; Department of Surgery, Nara Medical University, Kashihara, Nara, Japan.
  • Ikoma H; Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Nakai T; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka, Japan.
  • Kabata D; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Shinkawa H; Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Kobayashi S; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Hirokawa F; Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Mori H; Division of Gastrointestinal, Breast, and General Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
  • Hayami S; Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.
  • Morimura R; Department of Surgery, Nara Medical University, Kashihara, Nara, Japan.
  • Matsumoto M; Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Ishizawa T; Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Kaibori M; Department of Surgery, Hirakata Hospital, Kansai Medical University, Hirakata, Osaka, Japan.
J Gastrointest Surg ; 27(2): 283-295, 2023 02.
Article en En | MEDLINE | ID: mdl-36471191
BACKGROUNDS: Liver resection for hepatocellular carcinoma (HCC) in patients with Child-Pugh class (CPC) B increases the incidence of postoperative complication and in-hospital death and decreases the disease-free survival (DFS) and overall survival (OS) compared with those with CPC A. Conversely, some selected patients possibly gained benefits for liver resection. METHODS: Clinical records of 114 patients with CPC B who underwent liver resection for HCC were retrospectively reviewed. The risk of postoperative complications (Clavien-Dindo classification grade of ≥ II), postoperative recurrence, and death was analyzed. RESULTS: Postoperative complications occurred in 36 patients (31.6%), and 2 died within 90 days postoperatively due to the liver and respiratory failure, respectively. Multivariate analysis indicated that albumin-bilirubin (ALB) grade III and extended operation time were found as independent risk factors for postoperative complications. The DFS and OS rates at 3/5 years after liver resection were 30.8%/25.3% and 68.4%/48.9%, respectively. Multivariate analysis indicated that the extended blood loss, high α-fetoprotein (AFP) level (≥ 200 ng/mL), and Barcelona Clinic Liver Cancer stage C were found to be independent risk factors for postoperative recurrence. The high AFP level was also an independent prognostic factor for OS. Patients with high AFP levels had postoperative recurrence within 2 years and a higher number of extrahepatic recurrences than those with low AFP levels (< 200 ng/mL). CONCLUSION: For patients with HCC with CPC B who were scheduled for liver resection, ALBI grade III and high AFP level should be considered as unfavorable outcomes after liver resection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Gastrointest Surg Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Gastrointest Surg Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
...